SELLAS Life Sciences (SLS) Return on Equity (2020 - 2023)
Historic Return on Equity for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to 0.87%.
- SELLAS Life Sciences' Return on Equity rose 761700.0% to 0.87% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.87%, marking a year-over-year increase of 761700.0%. This contributed to the annual value of 24.24% for FY2023, which is 275100.0% up from last year.
- SELLAS Life Sciences' Return on Equity amounted to 0.87% in Q3 2024, which was up 761700.0% from 2.78% recorded in Q2 2024.
- SELLAS Life Sciences' 5-year Return on Equity high stood at 6.42% for Q4 2023, and its period low was 77.04% during Q3 2023.
- Over the past 5 years, SELLAS Life Sciences' median Return on Equity value was 2.19% (recorded in 2020), while the average stood at 7.16%.
- In the last 5 years, SELLAS Life Sciences' Return on Equity crashed by -742600bps in 2023 and then skyrocketed by 761700bps in 2024.
- SELLAS Life Sciences' Return on Equity (Quarter) stood at 0.95% in 2020, then fell by -14bps to 1.08% in 2021, then plummeted by -346bps to 4.81% in 2022, then surged by 233bps to 6.42% in 2023, then tumbled by -114bps to 0.87% in 2024.
- Its last three reported values are 0.87% in Q3 2024, 2.78% for Q2 2024, and 31.13% during Q1 2024.